↓ Skip to main content

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Overview of attention for article published in Journal of Hematology & Oncology, September 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
2 news outlets
twitter
2 X users
patent
7 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
510 Dimensions

Readers on

mendeley
564 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Published in
Journal of Hematology & Oncology, September 2019
DOI 10.1186/s13045-019-0779-5
Pubmed ID
Authors

Akintunde Akinleye, Zoaib Rasool

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 564 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 564 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 88 16%
Student > Master 68 12%
Student > Ph. D. Student 65 12%
Researcher 56 10%
Student > Doctoral Student 24 4%
Other 52 9%
Unknown 211 37%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 117 21%
Medicine and Dentistry 70 12%
Pharmacology, Toxicology and Pharmaceutical Science 31 5%
Agricultural and Biological Sciences 25 4%
Immunology and Microbiology 25 4%
Other 66 12%
Unknown 230 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2023.
All research outputs
#1,233,243
of 24,380,426 outputs
Outputs from Journal of Hematology & Oncology
#59
of 1,260 outputs
Outputs of similar age
#26,595
of 344,705 outputs
Outputs of similar age from Journal of Hematology & Oncology
#3
of 19 outputs
Altmetric has tracked 24,380,426 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,260 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,705 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.